Skip Navigation

MPS-5.4 Data Details

MPS-5.4 Reduce emergency department (ED) visits for medication overdoses among children less than 5 years of age

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Population Estimates; U.S. Census Bureau (Census)
National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES); Centers for Disease Control and Prevention and Consumer Product Safety Commission and Food and Drug Administration (CDC and CPSC and FDA)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 10,000 
Baseline (Year)
32.7 (2007-2008)
Target
29.4
Target-Setting Method
10 percent improvement
Numerator
Estimated number of ED visits for medication overdoses among children <5 years of age
Denominator
Estimated number of children in the U.S. <5 years of age from bridged-race population estimates from the U.S. Census Bureau
Data Collection Frequency
Biennial
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

The denominator measure for the indicator: “Reduce emergency department (ED) visits for medication overdoses among children <5 years of age” is different than the denominator for the other indicators regarding rate of ED visits for medication overdose.

The denominator for this measure is the U.S. resident population of children <5 years of age (rather than a measure of medications prescribed for these children) because over 80% of ED visits for overdoses among children <5 years old are due to unsupervised ingestions, very often ingestion of medications prescribed or intended to be used by another older child or an adult. Thus, the population of children <5 years of age (rather than children <5 years of age who are prescribed medications) is the best measure of the population at risk.

To calculate the numerator: The cause/mechanism of each adverse drug event visit is coded as allergic reaction, side-effect or overdose. Only ED visits due to overdoses are included in the numerator.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The original baseline was revised from 32.8 to 32.7 due to a change in the baseline year from 2008 to 2007-2008. The target was adjusted from 29.5 to 29.4 to reflect the revised baseline using the original target-setting method.

References

Additional resources about the objective.

  1. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296:1858-66.
  2. Cohen AL, Budnitz DS, Weidenbach KN, Jernigan DB, Schroeder TJ, Shehab N, Pollock DA. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr 2008;152: 416-421.
  3. Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (NEISS-CADES). Medical Care 2007;45 (suppl 2):S96-S102.